Home/Filings/4/0001181431-04-059485
4//SEC Filing

LIBERTY MINT LTD 4

Accession 0001181431-04-059485

CIK 0001042420operating

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 10:09 AM ET

Size

5.4 KB

Accession

0001181431-04-059485

Insider Transaction Report

Form 4
Period: 2004-12-09
Kinsella Kevin J
Director10% Owner
Transactions
  • Award

    Common Stock

    2004-12-09+2,788,5772,788,577 total
Footnotes (1)
  • [F1]Shares received in exchange for shares of Akesis Pharmaceuticals, Inc. (a privately held corporation) common stock held by Mr. Kinsella in connection with the merger of Ann Arbor Acquisition Corporation, a wholly-owned subsidiary of Liberty Mint, Ltd., with and into Akesis Pharmaceuticals, Inc. Akesis Pharmaceuticals is the surviving corporation and stockholders of Akesis Pharmaceuticals, including Mr. Kinsella, received their pro rata share of approximately 10,500,000 shares of Liberty Mint, Ltd. common stock. On December 9, 2004, the effective date of the merger, the closing price of Liberty Mint, Ltd. common stock was $5.75 per share.

Documents

1 file

Issuer

LIBERTY MINT LTD

CIK 0001042420

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001042420

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 10:09 AM ET
Size
5.4 KB